Skip to main content

Peer Review reports

From: Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin

Original Submission
1 Feb 2022 Submitted Original manuscript
6 Apr 2022 Reviewed Reviewer Report - Mark Wansbrough-Jones
16 Apr 2022 Reviewed Reviewer Report - Riaz Qureshi
23 Apr 2022 Reviewed Reviewer Report - Laurent Marsollier
17 May 2022 Author responded Author comments - Roch Christian JOHNSON
Resubmission - Version 2
17 May 2022 Submitted Manuscript version 2
Publishing
9 Jun 2022 Editorially accepted
8 Jul 2022 Article published 10.1186/s13063-022-06473-9

You can find further information about peer review here.

Back to article page